PHAXIAM Therapeutics S.A.
PHXM · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,287 | – | – | $796 |
| Dep. & Amort. | $469 | – | – | $1,667 |
| Deferred Tax | $0 | – | – | -$3,216 |
| Stock-Based Comp. | $0 | – | – | -$9,988 |
| Change in WC | -$2,391 | – | – | -$5,123 |
| Other Non-Cash | $660 | – | – | $4,764 |
| Operating Cash Flow | -$12,549 | – | – | -$11,100 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$164 | – | – | -$78 |
| Net Acquisitions | $22 | – | – | $1 |
| Inv. Purchases | -$4 | – | – | $0 |
| Inv. Sales/Matur. | $127 | – | – | $257 |
| Other Inv. Act. | $0 | – | – | $0 |
| Investing Cash Flow | -$19 | – | – | $180 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | – | – | $0 |
| Stock Issued | $0 | – | – | $0 |
| Stock Repurch. | $0 | – | – | $0 |
| Dividends Paid | $0 | – | – | $0 |
| Other Fin. Act. | -$2,081 | – | – | -$3,726 |
| Financing Cash Flow | -$2,081 | – | – | -$3,726 |
| Forex Effect | $0 | – | – | $96 |
| Net Chg. in Cash | $0 | – | – | -$14,550 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,189 | – | – | $53,339 |
| End Cash | $10,474 | – | – | $38,789 |
| Free Cash Flow | -$12,713 | – | – | -$11,178 |